Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Agnelli

Showing results (81-90 of 111) with videos related to

Pageof 12
Sort By:
NPJ Precision Oncology|December 15, 2025
Benchmarking progression-free survival ratio as primary endpoint in precision oncology clinical trialsFederico Nichetti, Jennifer Hüllein, Pauline du Rusquec, et al.
Frontiers in Digital Health|December 15, 2025
UpSMART: five years of digital innovation in cancer clinical research-achievements, challenges, and recommendationsPaul O'Regan, Fouziah Butt, Louise Carter, et al.
British Journal of Haematology|March 4, 2014
High-throughput sequencing for the identification of NOTCH1 mutations in early stage chronic lymphocytic leukaemia: biological and clinical implicationsMarta Lionetti, Sonia Fabris, Giovanna Cutrona, et al.
Plos One|March 19, 2015
Insulin growth factor 1 receptor expression is associated with NOTCH1 mutation, trisomy 12 and aggressive clinical course in chronic lymphocytic leukaemiaFrancesco Maura, Laura Mosca, Sonia Fabris, et al.
Nature Medicine|May 13, 2014
Rescue of Hippo coactivator YAP1 triggers DNA damage-induced apoptosis in hematological cancersFrancesca Cottini, Teru Hideshima, Chunxiao Xu, et al.
Cancer Gene Therapy|July 10, 2026
PYGO2 is overexpressed in multiple myeloma patients with 1q21 amplification, driving plasma cell proliferation and cell cycle progressionNicolas Thomas Iannozzi, Paola Storti, Rosanna Vescovini, et al.
Blood|October 15, 2015
Identification of a new subclass of ALK-negative ALCL expressing aberrant levels of ERBB4 transcriptsIrene Scarfò, Elisa Pellegrino, Elisabetta Mereu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 12, 2014
microRNAome expression in chronic lymphocytic leukemia: comparison with normal B-cell subsets and correlations with prognostic and clinical parametersMassimo Negrini, Giovanna Cutrona, Cristian Bassi, et al.
Tumori|September 23, 2024
Is tumour sequencing effective for the identification of germline <i>BRCA1/2</i> pathogenic variant carriers?Jacopo Azzollini, Iolanda Capone, Matteo Duca, et al.
Haematologica|October 15, 2020
The new small tyrosine kinase inhibitor ARQ531 targets acute myeloid leukemia cells by disrupting multiple tumor-addicted programsDebora Soncini, Stefania Orecchioni, Samantha Ruberti, et al.
Pageof 12

Showing results (81-90 of 111) with videos related to

Sort By:
Pageof 12
NPJ Precision Oncology|December 15, 2025
Benchmarking progression-free survival ratio as primary endpoint in precision oncology clinical trialsFederico Nichetti, Jennifer Hüllein, Pauline du Rusquec, et al.
Frontiers in Digital Health|December 15, 2025
UpSMART: five years of digital innovation in cancer clinical research-achievements, challenges, and recommendationsPaul O'Regan, Fouziah Butt, Louise Carter, et al.
British Journal of Haematology|March 4, 2014
High-throughput sequencing for the identification of NOTCH1 mutations in early stage chronic lymphocytic leukaemia: biological and clinical implicationsMarta Lionetti, Sonia Fabris, Giovanna Cutrona, et al.
Plos One|March 19, 2015
Insulin growth factor 1 receptor expression is associated with NOTCH1 mutation, trisomy 12 and aggressive clinical course in chronic lymphocytic leukaemiaFrancesco Maura, Laura Mosca, Sonia Fabris, et al.
Nature Medicine|May 13, 2014
Rescue of Hippo coactivator YAP1 triggers DNA damage-induced apoptosis in hematological cancersFrancesca Cottini, Teru Hideshima, Chunxiao Xu, et al.
Cancer Gene Therapy|July 10, 2026
PYGO2 is overexpressed in multiple myeloma patients with 1q21 amplification, driving plasma cell proliferation and cell cycle progressionNicolas Thomas Iannozzi, Paola Storti, Rosanna Vescovini, et al.
Blood|October 15, 2015
Identification of a new subclass of ALK-negative ALCL expressing aberrant levels of ERBB4 transcriptsIrene Scarfò, Elisa Pellegrino, Elisabetta Mereu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 12, 2014
microRNAome expression in chronic lymphocytic leukemia: comparison with normal B-cell subsets and correlations with prognostic and clinical parametersMassimo Negrini, Giovanna Cutrona, Cristian Bassi, et al.
Tumori|September 23, 2024
Is tumour sequencing effective for the identification of germline <i>BRCA1/2</i> pathogenic variant carriers?Jacopo Azzollini, Iolanda Capone, Matteo Duca, et al.
Haematologica|October 15, 2020
The new small tyrosine kinase inhibitor ARQ531 targets acute myeloid leukemia cells by disrupting multiple tumor-addicted programsDebora Soncini, Stefania Orecchioni, Samantha Ruberti, et al.
Pageof 12